Sanofi
Latest statistics and disclosures from Sanofi's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MGTX, INBX, NVAX, ANAB, IMRX, and represent 94.18% of Sanofi's stock portfolio.
- Added to shares of these 1 stock: MPLT (+$16M).
- Started 1 new stock position in MPLT.
- Reduced shares in these 2 stocks: OMDA (-$12M), LVTX.
- Sold out of its positions in OMDA, LVTX.
- Sanofi was a net buyer of stock by $1.4M.
- Sanofi has $310M in assets under management (AUM), dropping by 19.22%.
- Central Index Key (CIK): 0001121404
Tip: Access up to 7 years of quarterly data
Positions held by Sanofi consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sanofi
Sanofi holds 8 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Meiragtx Holdings (MGTX) | 31.2 | $97M | 12M | 7.95 |
|
|
| Inhibrx Biosciences (INBX) | 29.5 | $92M | 1.2M | 79.00 |
|
|
| Novavax Com New (NVAX) | 14.9 | $46M | 6.9M | 6.72 |
|
|
| Anaptysbio Inc Common (ANAB) | 12.8 | $40M | 822k | 48.48 |
|
|
| Immuneering Corp Class A Com (IMRX) | 5.7 | $18M | 2.7M | 6.58 |
|
|
| Maplight Therapeutics (MPLT) | 5.2 | $16M | NEW | 912k | 17.57 |
|
| Eledon Pharmaceuticals (ELDN) | 0.4 | $1.2M | 815k | 1.51 |
|
|
| Q32 Bio (QTTB) | 0.3 | $810k | 244k | 3.32 |
|
Past Filings by Sanofi
SEC 13F filings are viewable for Sanofi going back to 2025
- Sanofi 2025 Q4 filed Feb. 11, 2026
- Sanofi 2025 Q3 filed Nov. 4, 2025
- Sanofi 2025 Q2 filed July 29, 2025